IGM Biosciences, Inc. Research and Development Expense
IGM Biosciences, Inc. reported Research and Development Expense of $5.86 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2025-07-31
- IGM Biosciences, Inc. research and development expense for the quarter ending 2025-06-30 was $5.86M, a 86.03% decline year-over-year.
- IGM Biosciences, Inc. research and development expense for the quarter ending 2025-03-31 was $22.34M, a 49.02% decline year-over-year.
- IGM Biosciences, Inc. research and development expense for the quarter ending 2024-12-31 was $28.93M, a 46.60% decline year-over-year.
- IGM Biosciences, Inc. research and development expense for the quarter ending 2024-09-30 was $46.14M, a 15.74% decline year-over-year.
- IGM Biosciences, Inc. research and development expense for fiscal 2024 was $160.85M, a 25.36% decline from fiscal 2023.
- IGM Biosciences, Inc. research and development expense for fiscal 2023 was $215.52M, a 20.21% increase from fiscal 2022.
- IGM Biosciences, Inc. research and development expense for fiscal 2022 was $179.29M, a 41.14% increase from fiscal 2021.
- IGM Biosciences, Inc. research and development expense for fiscal 2021 was $127.03M, a 95.33% increase from fiscal 2020.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2025-06-30 | $5.86M 10-Q · filed 2025-07-31 | $28.20M 10-Q · filed 2025-07-31 | $57.13M derived: sum of 3 quarters · filed 2025-07-31 | $103.28M derived: sum of 4 quarters · filed 2025-07-31 |
| 2025-03-31 | $22.34M 10-Q · filed 2025-05-13 | $51.27M derived: sum of 2 quarters · filed 2025-05-13 | $97.41M derived: sum of 3 quarters · filed 2025-05-13 | $139.38M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-12-31 | $28.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $75.08M derived: sum of 2 quarters · filed 2025-03-06 | $117.04M derived: sum of 3 quarters · filed 2025-07-31 | $160.85M 10-K · filed 2025-03-06 |
| 2024-09-30 | $46.14M 10-Q · filed 2024-11-08 | $88.10M derived: sum of 2 quarters · filed 2025-07-31 | $131.92M 10-Q · filed 2024-11-08 | $186.11M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-06-30 | $41.96M 10-Q · filed 2025-07-31 | $85.78M 10-Q · filed 2025-07-31 | $139.97M derived: sum of 3 quarters · filed 2025-07-31 | $194.73M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $43.81M 10-Q · filed 2025-05-13 | $98.00M derived: sum of 2 quarters · filed 2025-05-13 | $152.77M derived: sum of 3 quarters · filed 2025-05-13 | $208.44M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $54.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $108.95M derived: sum of 2 quarters · filed 2025-03-06 | $164.63M derived: sum of 3 quarters · filed 2025-03-06 | $215.52M 10-K · filed 2025-03-06 |
| 2023-09-30 | $54.76M 10-Q · filed 2024-11-08 | $110.44M derived: sum of 2 quarters · filed 2024-11-08 | $161.33M 10-Q · filed 2024-11-08 | $206.35M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-06-30 | $55.67M 10-Q · filed 2024-08-14 | $106.57M 10-Q · filed 2024-08-14 | $151.58M derived: sum of 3 quarters · filed 2025-03-06 | $199.76M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-03-31 | $50.89M 10-Q · filed 2024-05-08 | $95.91M derived: sum of 2 quarters · filed 2025-03-06 | $144.09M derived: sum of 3 quarters · filed 2025-03-06 | $191.31M derived: sum of 4 quarters · filed 2025-03-06 |
| 2022-12-31 | $45.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $93.20M derived: sum of 2 quarters · filed 2025-03-06 | $140.41M derived: sum of 3 quarters · filed 2025-03-06 | $179.29M 10-K · filed 2025-03-06 |
| 2022-09-30 | $48.18M 10-Q · filed 2023-11-13 | $95.40M derived: sum of 2 quarters · filed 2023-11-13 | $134.27M 10-Q · filed 2023-11-13 | $173.44M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | $47.22M 10-Q · filed 2023-08-03 | $86.09M 10-Q · filed 2023-08-03 | $125.26M derived: sum of 3 quarters · filed 2024-03-07 | $159.46M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | $38.88M 10-Q · filed 2023-05-12 | $78.04M derived: sum of 2 quarters · filed 2024-03-07 | $112.24M derived: sum of 3 quarters · filed 2024-03-07 | $142.33M derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | $39.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $73.36M derived: sum of 2 quarters · filed 2024-03-07 | $103.45M derived: sum of 3 quarters · filed 2024-03-07 | $127.03M 10-K · filed 2024-03-07 |
| 2021-09-30 | $34.20M 10-Q · filed 2022-11-03 | $64.28M derived: sum of 2 quarters · filed 2022-11-03 | $87.86M 10-Q · filed 2022-11-03 | $107.46M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $30.09M 10-Q · filed 2022-08-08 | $53.66M 10-Q · filed 2022-08-08 | $73.26M derived: sum of 3 quarters · filed 2022-08-08 | $89.09M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $23.57M 10-Q · filed 2022-05-09 | $43.17M derived: sum of 2 quarters · filed 2022-05-09 | $59.00M derived: sum of 3 quarters · filed 2022-05-09 | $74.02M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $19.60M 10-K · filed 2021-03-30 | $35.43M derived: sum of 2 quarters · filed 2021-11-04 | $50.45M derived: sum of 3 quarters · filed 2021-11-04 | $65.03M 10-K · filed 2023-03-30 |
| 2020-09-30 | $15.83M 10-Q · filed 2021-11-04 | $30.85M derived: sum of 2 quarters · filed 2021-11-04 | $45.43M 10-Q · filed 2021-11-04 | $58.19M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $15.02M 10-Q · filed 2021-08-09 | $29.60M 10-Q · filed 2021-08-09 | $42.37M derived: sum of 3 quarters · filed 2021-08-09 | $50.64M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $14.58M 10-Q · filed 2021-05-06 | $27.35M derived: sum of 2 quarters · filed 2021-05-06 | $35.63M derived: sum of 3 quarters · filed 2021-05-06 | $43.93M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $12.76M 10-K · filed 2021-03-30 | $21.04M derived: sum of 2 quarters · filed 2021-03-30 | $29.34M derived: sum of 3 quarters · filed 2021-03-30 | $35.26M 10-K · filed 2022-03-29 |
| 2019-09-30 | $8.28M 10-K · filed 2021-03-30 | $16.58M derived: sum of 2 quarters · filed 2021-03-30 | $22.49M 10-Q · filed 2020-11-05 | $30.31M derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-06-30 | $8.30M 10-K · filed 2021-03-30 | $14.21M 10-Q · filed 2020-08-06 | $22.03M derived: sum of 3 quarters · filed 2021-03-30 | $27.20M derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-03-31 | $5.91M 10-K · filed 2021-03-30 | $13.73M derived: sum of 2 quarters · filed 2021-03-30 | $18.90M derived: sum of 3 quarters · filed 2021-03-30 | $22.35M derived: sum of 4 quarters · filed 2021-03-30 |
| 2018-12-31 | $7.81M 10-K · filed 2020-03-26 | $12.99M derived: sum of 2 quarters · filed 2020-03-26 | $16.44M derived: sum of 3 quarters · filed 2020-03-26 | $18.96M 10-K · filed 2021-03-30 |
| 2018-09-30 | $5.17M 10-K · filed 2020-03-26 | $8.62M derived: sum of 2 quarters · filed 2020-03-26 | $11.15M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $3.45M 10-K · filed 2020-03-26 | $5.98M derived: sum of 2 quarters · filed 2020-03-26 | ||
| 2018-03-31 | $2.53M 10-K · filed 2020-03-26 | |||
| 2017-12-31 | $8.64M 10-K · filed 2020-03-26 |